Thomas S. Hall Joins NovaMed as President and Chief Executive Officer


CHICAGO -- NovaMed, Inc. today announced that its board of directors has named Thomas S. Hall as president and chief executive officer, effective Nov. 14, 2005. Hall will also join NovaMed's board. Hall fills the position left vacant by the death of Stephen J. Winjum, former chairman, president and CEO.

Hall previously served as president and chief operating officer of Matria Healthcare, Inc. since April 2003, after having joined Matria in October 2002 as executive vice president and COO. Matria provides comprehensive disease management programs to health plans and employers. Prior to joining Matria, Hall was president of ADP TotalSource, a division of Automated Data Processing, Inc. Hall also served in senior management positions with Riscorp, Inc., an insurance holding company, and USAir Express/Chautauqua Airlines. Hall earned a BA in business from Goshen College and a MBA from Clarkson University.

NovaMed's board of directors also appointed Robert J. Kelly to serve as its non-executive chairman. Kelly has served as presiding director of NovaMed since March 29, 2005. "We are extremely pleased to have Tom Hall join NovaMed," said Kelly. "Tom has an outstanding record of accomplishments and the Board as well as our management team look forward to working with him to continue to grow our business."

Hall commented, "Joining NovaMed is an exciting opportunity for me personally. NovaMed is a solid company in an attractive industry with plenty of growth opportunities. I look forward to leading this organization and building on the company's recent track record and growth momentum."

In aligning Hall's interests with those of NovaMed stockholders, Hall's compensation package includes 250,000 restricted shares of NovaMed common stock and non-qualified options to purchase another 250,000 shares. These awards will vest over four years in a manner consistent with the company's traditional vesting schedule for its employees. In recruiting Hall, NovaMed issued the restricted stock award in reliance on Section 4350(i)(1)(A)(iv) of the Nasdaq Marketplace Rules.

NovaMed acquires, develops and operates ambulatory surgery centers in partnership with physicians. NovaMed currently has ownership interests in 27 surgery centers located in 14 states. NovaMed's executive offices are located in Chicago.

Source: NovaMed


Similar Articles

comments powered by Disqus